(Q40413758)

20 September 2017

title

Emotional responses to APO E genotype disclosure for Alzheimer disease (English)

1 reference

20 September 2017

0 references

Linda J Romero

1

1 reference

20 September 2017

Philip J Garry

2

1 reference

20 September 2017

Mark Schuyler

3

1 reference

20 September 2017

David A Bennahum

4

1 reference

20 September 2017

Clifford Qualls

5

1 reference

20 September 2017

Lori Ballinger

6

1 reference

20 September 2017

Velma Kelly

7

1 reference

20 September 2017

Cheryl Schmitt

8

1 reference

20 September 2017

Betty Skipper

9

1 reference

20 September 2017

Irene E Ortiz

10

1 reference

20 September 2017

Robert L Rhyne

11

1 reference

20 September 2017

publication date

1 April 2005

1 reference

Journal of Genetic Counseling

20 September 2017

published in

1 reference

20 September 2017

volume

14

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

141-150

1 reference

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing

20 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10897-005-4063-1

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

12 December 2020

Apolipoprotein E genotyping in the diagnosis of alzheimer's disease: A cautionary view

1 reference

12 December 2020

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

1 reference

12 December 2020

Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences

1 reference

12 December 2020

Adult and geriatric normative data and validation of the profile of mood states

1 reference

12 December 2020

Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease

1 reference

12 December 2020

Recognition and treatment of depression in a primary care setting

1 reference

12 December 2020

DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.

1 reference

12 December 2020

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

1 reference

12 December 2020

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes

1 reference

12 December 2020

1 reference

12 December 2020

Case-finding instruments for depression. Two questions are as good as many

1 reference

12 December 2020

Estimated prevalence of Alzheimer's disease in the United States

1 reference

12 December 2020

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

1 reference

12 December 2020

Psychological responses to BRCA1 mutation testing: preliminary findings.

1 reference

12 December 2020

Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease

1 reference

12 December 2020

On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease

1 reference

12 December 2020

Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

1 reference

12 December 2020

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

12 December 2020

Development and validation of a geriatric depression screening scale: a preliminary report

1 reference

12 December 2020

10.1007/S10897-005-4063-1

Identifiers

DOI

1 reference

20 September 2017

1 reference